<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure
2
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives
3
Hepatitis C outbreak astounds Spain
4
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
5
Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population
6
Hepatitis C Rapid Point-of-Care Testing and Laboratory-based Non-invasive Assessment of Liver Fibrosis among Drug Abusers: An Experience from Iran
7
Hepatitis C seropositivity in patients with acute and chronic urticaria
8
Hepatitis C seroprevalence among intravenous drug users in Tehran
9
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system
10
Hepatitis C therapy in treatment-naïve patients
11
Hepatitis C transmission associated with intravenous immunoglobulins
12
Hepatitis C transmission by cosmetic tattooing in women
13
Hepatitis C Treatment Among People Who Use Drugs in an Office-Based Opioid Treatment Program Versus a Syringe Exchange Program: A Real-World Prospective Clinical Trial
14
Hepatitis C treatment update
15
Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan
16
Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules
17
Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin
18
Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy
19
Hepatitis C viral life cycle
20
Hepatitis C virus
21
Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents
22
Hepatitis C Virus (HCV) “A Possible Independent Risk Factor” for Coronary Artery Disease
23
Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells
24
Hepatitis C virus (HCV) genotype 1B infection is associated with a high incidence of graft cirrhosis after liver transplantation (OLT)
25
Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
26
Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection
27
Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan
28
Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction
29
Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital
30
Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection
31
Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia
32
Hepatitis C virus (HCV)-infection and oral lichen planus
33
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran
34
Hepatitis C virus and blood transfusion: past and present risks
35
Hepatitis C virus and hepatocellular carcinoma
36
Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection
37
Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria.
38
Hepatitis C virus and kidney disease
39
Hepatitis C Virus and Lichen Planus: The Real Association
40
Hepatitis C virus and liver steatosis: when fat is not beautiful
41
Hepatitis C Virus and Vaccine Development
42
Hepatitis C Virus Antibodies and Vitiligo Disease
43
Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran
44
Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan
45
Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection
46
Hepatitis C virus assembly: When fat makes it easier
47
Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and Its Association With Hepatic Steatosis
48
Hepatitis C virus challenges AIDS associated viruses at the transfusion crossings: the place and time for a second trial
49
Hepatitis C virus clearance improves quality of life
50
Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
51
Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals
52
Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b
53
Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression
54
Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes
55
Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication
56
Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation
57
Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation
58
Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2
59
Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation
60
Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications
61
Hepatitis C Virus Cryoglobulinemia and non-Hodgkin Lymphoma
62
Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients
63
Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein
64
Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response
65
Hepatitis C virus genetic variability in patients undergoing antiviral therapy
66
Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-β-lipoproteinemia
67
Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran
68
Hepatitis C Virus Genotypes and Association With Viral Load in Yazd, Central Province of Iran
69
Hepatitis C virus genotypes and quasispecies
70
Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
71
HEPATITIS C VIRUS GENOTYPES IN A NORTHEASTERN AREA OF BRAZIL
72
Hepatitis C virus genotypes in Adana and Antakya regions of Turkey
73
HEPATITIS C VIRUS GENOTYPES IN BAHAWALPUR
74
Hepatitis C virus genotypes in elderly patients with chronic hepatitis C
75
HEPATITIS C VIRUS GENOTYPES IN IRAQ
76
Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013)
77
Hepatitis C virus Genotypes in Patients with End-Stage Renal Disease in East Azerbaijan, Iran
78
Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples
79
Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran
80
Hepatitis C virus in blood donation
81
Hepatitis C virus in breast milk
82
Hepatitis C virus in elderly patients with chronic liver diseases
83
HEPATITIS C VIRUS IN IRAN: EPIDEMIOLOGY OF AN EMERGING INFECTION
84
Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
85
Hepatitis C Virus in North Africa: An Emerging Threat
86
Hepatitis C virus in people with HIV infection
87
Hepatitis C virus in people with HIV infection
88
Hepatitis C virus in saliva of haemophiliac patients attending an oral surgery unit
89
Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C
90
Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy
91
Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk
92
Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran
93
Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt
94
Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran
95
Hepatitis C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study
96
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town
97
Hepatitis C virus infection and autoimmune thrombocytopenic purpura
98
Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease
99
Hepatitis C virus infection and cryoglobulinemia
100
Hepatitis C virus infection and genotypes in blood donors
101
Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients
102
Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians
103
Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France
104
Hepatitis C virus infection and primary Sjögrenʹs Syndrome: A clinical and serologic description of 9 patients
105
Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt
106
Hepatitis C Virus Infection Complicated by Kidney Disease
107
Hepatitis C Virus Infection in Blood Donors: An Emerging Risk to Transfusion Services
108
Hepatitis C virus infection in children
109
Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study
110
Hepatitis C virus infection in dialysis patients
111
Hepatitis C virus infection in Eastern Europe
112
Hepatitis C virus infection in hemodialysis patients in Sudan: Two centers report
113
Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures
114
Hepatitis C Virus Infection in Isfahan, Iran: A Review Article
115
Hepatitis C virus infection in nephrology patients
116
Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-ControlStudy
117
HEPATITIS C VIRUS INFECTION IN PATIENTS ON LONG TERM HEMODIALYSIS
118
Hepatitis C Virus Infection in Patients with Hemophilia in Isfahan, Iran
119
Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication
120
Hepatitis C virus infection in special groups
121
Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
122
Hepatitis C virus infection in the United States
123
Hepatitis C virus infection in Western Europe
124
Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis
125
Hepatitis C virus infection of salivary gland epithelial cells : Lack of evidence
126
Hepatitis C Virus Infection Trends in Italy
127
Hepatitis C Virus Infection Trends in Italy, 1996–2006
128
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
129
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?
130
Hepatitis C virus infection, tuberculosis, and sexually transmitted diseases
131
Hepatitis C virus infection: co-infection with HIV and HBV
132
Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in I.R. IRAN
133
Hepatitis C virus infection: quality of life and side effects of treatment
134
Hepatitis C virus infection: when silence is deception
135
Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment
136
Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation
137
Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture
138
Hepatitis C virus NS3 NTPase/Helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step
139
Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Original Research Article
140
Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR Original Research Article
141
Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding
142
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of moiety with improved potency
143
Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034
144
Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency
145
Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death
146
Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt
147
Hepatitis C Virus RNA (HCV-RNA) in Blood Donors and Family Members Seropositive for Anti-HCV Antibodies
148
Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L
149
Hepatitis C virus RNAs replicating in cell culture
150
Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department
151
Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity
152
Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran
153
Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine
154
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
155
Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report
156
Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA
157
Hepatitis C virus transmission by intravenous immunoglobulin
158
Hepatitis C virus transmission by monoclonal- purified viral-attenuated factor VIII concentrate
159
Hepatitis C Virus Treatment Revolution: Eastern European Story
160
Hepatitis C Virus Treatment with Sofosbuvir Plus Ribavirin Regimen in Khuzestan Province
161
Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
162
Hepatitis C virus ultrastructure and morphogenesis.
163
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients
164
Hepatitis C virus, rheumatoid factors, and disease progression
165
Hepatitis C virus, Sjögrenʹs syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer
166
Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion : Edited by Harvey Reesink, 212, S. Karger AG, Basel, DM 290, ISBN 3-8055-5866-X
167
Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran
168
Hepatitis C Virus; Its Implication for Endodontists
169
Hepatitis C virus-related arthritis
170
Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C
171
Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy
172
Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level in Healthy, Anti-HCV-Negative Individuals
173
Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women
174
Hepatitis C with and without dermatological manifestations: comparison of human leukocyte antigen-DR types, circulating T-cell subsets, and relation to disease severity
175
Hepatitis C, ,
176
Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions
177
Hepatitis C. Biomedical Research Reports: T. Jake Liang and Jay H. Hoofnagle (Eds.), Academic Press, 2000, ISBN 0-12-447870-0, $99.95
178
HEPATITIS C: A COMMON BUT INFREQUENTLY TREATED DISEASE
179
HEPATITIS C: A LEADING CAUSE OF CIRRHOSIS AT DHQ HOSPITAL D.I.KHAN
180
Hepatitis C: molecular virology and antiviral targets
181
Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia
182
Hepatitis C: public health strategies
183
Hepatitis C: the clinical spectrum of the disease
184
Hepatitis C: the dermatologic profile
185
Hepatitis C-Associated Chronic Lymphoproliferative Disorders: A Single Center Experience
186
Hepatitis C-Associated Osteosclerosis After Blood Transfusion
187
Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults
188
Hepatitis C—virology and future antiviral targets
189
Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin
190
Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme levels and Histopathology-an Epidemiological Study in Shiraz, Southern Iran, 2003-2004
191
Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World
192
Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia
193
Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases
194
Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections
195
Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)
196
Hepatitis disease diagnosis using a new hybrid system based on feature selection (FS) and artificial immune recognition system with fuzzy resource allocation
197
Hepatitis DVirus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran
198
Hepatitis E antibodies and HIV status
199
Hepatitis E associated with surgical training on pigs
200
Hepatitis E in Brazil
201
HEPATITIS E SEROCONVERSION IN UNITED STATES TRAVELERS ABROAD
202
Hepatitis E Virus
203
Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death
204
Hepatitis E virus and HIV infection in homosexual men
205
Hepatitis E virus and pigs: A zoonotic risk in Europe?
206
Hepatitis E Virus and Renal Transplantation
207
Hepatitis E virus and serum level aminotransferases in blood donors
208
Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis
209
Hepatitis E virus genotyping based on full-length genome and partial genomic regions
210
Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants
211
Hepatitis E virus infection
212
Hepatitis E Virus Infection Among Chronic Hemodialysis
213
Hepatitis E Virus Infection Among Iranian Patients with Beta-Thalassemia
214
Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis
215
Hepatitis E Virus Infection in a Northern Mexican City: A Cross-Sectional Seroprevalence Study
216
Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Jahrom, Southern Iran
217
Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients
218
Hepatitis E Virus Infection in Macaca Mulatta
219
Hepatitis E Virus Infection: A Neglected Problem in Our Region
220
Hepatitis E virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR
221
Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran
222
Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report
223
Hepatitis E Virus Seroprevalence and Viremia in Hemodialysis and HIV Infected Patients in Iran
224
Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan province, Islamic Republic of Iran
225
Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran
226
Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate
227
Hepatitis E: a virus in waiting
228
Hepatitis E: An emerging awareness of an old disease
229
Hepatitis E: Risk and Prevention
230
Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection
231
Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection
232
Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan‑Iran
233
Hepatitis G virus in immunosuppressed paediatric allograft recipients
234
Hepatitis G virus in India
235
Hepatitis G virus in Karachi, Pakistan
236
Hepatitis G virus in long-term survivors of haematological malignancy
237
Hepatitis G virus infection
238
Hepatitis G virus infection
239
Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy
240
Hepatitis G Virus Infection in Iranian Blood Donors and High-Risk Groups
241
Hepatitis G-associated aplastic anaemia
242
Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany
243
Hepatitis in Ontario linked to EEG electrodes
244
Hepatitis induced by Kava (Piper methysticum rhizoma)
245
Hepatitis meeting suggests end of “carrier” status
246
Hepatitis Monthly, an International Journal in the Field of Hepatology
247
Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan — a cross-sectional descriptive study
248
Hepatitis treatment in developing countries
249
Hepatitis treatment moves on
250
Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma
251
Hepatitis virus infection and atherosclerosis: reply to Vassalle, Zucchelli and Giustini
252
Hepatitis Virus Infection and Hodgkin s Lymphoma: A Review of the Literature
253
Hepatitis virus infections in heart transplant recipients
254
Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment
255
Hepatitis viruses and the MAPK pathway: is this a survival strategy?
256
Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes
257
Hepatitis viruses in the XXI century
258
Hepatitis: A Rapidly Spreading Viral Infection in Pakistan
259
Hepatitis-B vaccine down under
260
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
261
Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran
262
Hepatitis-C Infection Incidence Among the non-Hodgkin’s B-cell Lymphoma Patients in the Northeast of Iran
263
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
264
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
265
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study
266
Hepatitis-C-virus risk from Italian fertility centre
267
Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women
268
Hepato- and Reno-Protective Impacts of Plantago major: An Experimental Model of Testicular Ischemia/Reperfusion
269
Hepato Protective and Antioxidant Role of Berberis tinctoria Lesch Leaves on Paracetamol Induced Hepatic Damage in Rats
270
Hepatoadrenal syndrome in Egyptian children with liver cirrhosis with and without sepsis
271
Hepatoatrial anastomosis and tricuspid valve replacement in budd-chiari syndrome 8.
272
Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis
273
Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study
274
Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen
275
Hepatobiliary Cystadenoma Mimicking Liver Hydatid Cyst
276
Hepatobiliary Cystadenoma with Mesenchymal Stroma Mistaken for Common Bile Duct Stone
277
Hepatobiliary excretion and brain distribution of caffeine in rats using microdialysis Original Research Article
278
Hepatobiliary excretion of 99mTc-EC: A potential source of mistake in the interpretation of renal scintigraphy
279
Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR−) Rats
280
Hepatobiliary Fascioliasis: Clinical and Radiological Features
281
Hepatobiliary Involvement in Neonates With COVID-19 Infection: A Narrative Review
282
Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride
283
Hepatobiliary scintigraphy: An effective tool in the management of bile leak following laparoscopic cholecystectomy
284
Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients
285
Hepatobiliary surgery
286
HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief
287
Hepatobiliary Surgery and Nutrition is indexed by SCIE: a tremendous step forward
288
Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth
289
Hepatobiliary transport
290
Hepatobiliary, renal and bone complications of intestinal failure
291
Hepatoblastoma in a 2-year-old child of a liver-transplanted mother
292
Hepatoblastoma in a patient with a partial trisomy 9p syndrome: a case report
293
Hepatoblastoma Related Tumor Thrombosis Extended to IVC, Ra and Pulmonary Artery Branches: A Case Report
294
Hepatoblastomas in Oman
295
Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
296
Hepatocarcinogenesis: A polygenic model of inherited predisposition to cancer
297
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
298
Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise
299
Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli
300
Hepatocellular adenomas in patients taking danazol for here ditary angiooedema
301
Hepatocellular Cancer: A Guide for the Internist
302
Hepatocellular carcinoma
303
Hepatocellular carcinoma
304
Hepatocellular carcinoma
305
Hepatocellular carcinoma
306
Hepatocellular carcinoma
307
Hepatocellular carcinoma
308
Hepatocellular carcinoma
309
Hepatocellular carcinoma
310
Hepatocellular carcinoma (HCC) recurrence and what to do when it happens
311
Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment
312
Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol
313
Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company
314
Hepatocellular carcinoma and extrahepatic primary malignancy
315
Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran
316
Hepatocellular carcinoma and the art of prognostication
317
Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?
318
Hepatocellular carcinoma development in cirrhosis
319
Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier
320
Hepatocellular carcinoma from diagnosis to treatment: 15 years of challenges and modification of resection strategies
321
Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report
322
Hepatocellular Carcinoma in a non-B non-C Non-alcoholic Steatohepatitis (NBNC-NASH HCC)
323
Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal α-fetoprotein
324
Hepatocellular carcinoma in a young survivor of major burns
325
Hepatocellular carcinoma in alcoholics
326
Hepatocellular Carcinoma in Dog – Case Report
327
HEPATOCELLULAR CARCINOMA IN EGYPTIANS WITH AND WITHOUT A HISTORY OF HEPATITIS B VIRUS INFECTION: ASSOCIATION WITH HEPATITIS C VIRUS (HCV) INFECTION BUT NOT WITH HCV RNA LEVEL
328
Hepatocellular Carcinoma in Explanted Livers of Patients with Genotype D HBV Cirrhosis: Report of the First Experience from Iran
329
Hepatocellular Carcinoma in Pakistan: Where do We Stand?
330
Hepatocellular carcinoma in patients suffering from primary sclerosing cholangitis
331
Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors
332
Hepatocellular carcinoma in patients with HCV
333
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
334
Hepatocellular Carcinoma in Port Harcourt, Nigeria: Clinicopathologic Study of 75 Cases
335
Hepatocellular Carcinoma in Pregnancy with Unusual Presentations
336
Hepatocellular Carcinoma in Sheep.
337
Hepatocellular Carcinoma in Sheep.
338
Hepatocellular carcinoma in situs inversus totalis-a case report
339
Hepatocellular Carcinoma in the World and the Middle East
340
Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature
341
Hepatocellular Carcinoma is an Emerging Issue Now in Iran
342
Hepatocellular carcinoma markers in the omics era: the glycomic analysis
343
Hepatocellular carcinoma on the increase in USA
344
Hepatocellular carcinoma with disseminated skeletal muscle metastasis
345
Hepatocellular carcinoma with extension into the right atrium
346
Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature
347
Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
348
Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM
349
Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy
350
Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver
351
Hepatocellular Carcinoma: A Pledge for Evidence-based Medicine
352
Hepatocellular carcinoma: an entity needed to be differentiated
353
Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit
354
Hepatocellular Carcinoma: An Update
355
Hepatocellular carcinoma: beyond screening
356
Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Review
357
Hepatocellular Carcinoma: First Manifestation as SolitaryHumeral Bone Metastasis
358
Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches
359
Hepatocellular carcinoma: present status and future prospects
360
Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO
361
Hepatocellular Damage and Severity of COVID-19 Infection in Iraqi Patients: A Biochemical Study
362
Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective
363
Hepatocellular functions of human liver cells in oxygen-permeable membrane device Original Research Article
364
Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity
365
Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide
366
Hepatocellular oxidative stress and initial graft injury in human liver transplantation
367
Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels
368
Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury
369
Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?
370
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system
371
HepatoConsult: a knowledge-based second opinion and documentation system
372
Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata
373
Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
374
Hepatocyte and Islet Cell Cotransplantation on Poly-L-Lactide Matrix for the Treatment of Liver Cirrhosis
375
Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
376
Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor–ligand binding on hepatocyte spreading
377
Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels
378
Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces
379
Hepatocyte growth factor (HGF)-induced activation of the AP-1 complex : a comparison between normal and transformed rat hepatocytes
380
Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis
381
Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes
382
Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer
383
Hepatocyte growth factor and its actions in growth plate chondrocytes
384
Hepatocyte growth factor and placental development
385
Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease
386
Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
387
Hepatocyte growth factor in gingival crevicular fluid and the distribution of hepatocyte growth factor-activator in gingival tissue from adult periodontitis
388
Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells, ,
389
Hepatocyte growth factor induces activation of Nck and phospholipase C-γ in lung carcinoma cells
390
Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line
391
Hepatocyte growth factor inhibits insulin-stimulated glycogen synthesis in primary cultured hepatocytes
392
Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques
393
Hepatocyte growth factor level in the vitreou of patient with proliferative vitreoretinopathy
394
Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1α, and stem cell factor
395
Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis
396
Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis
397
Hepatocyte Growth Factor Regulation of Uterine Epithelial Cell Transepithelial Resistance and Tumor Necrosis Factor (alpha)Release in Culture
398
Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues
399
Hepatocyte growth factor/scatter factor, angiogenesis and tumour cell proliferation in primary breast cancer
400
Hepatocyte growth factor: a multifunctional cytokine
401
Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-κB
402
Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation
403
Hepatocyte Isolation From Unused/Rejected Livers for Transplantation: Initial Step Toward Hepatocyte Transplantation, the First Experience From Iran
404
Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis
405
Hepatocyte nuclear factor (HNF)-4α/γ, HNF-1α, and vHNF-1 regulate the cell-specific expression of the human dihydrodiol dehydrogenase (DD)4/AKR1C4 gene
406
Hepatocyte Nuclear Factor 1 α Controls Renal Expression of the Npt1-Npt4 Anionic Transporter Locus
407
Hepatocyte Nuclear Factor 4 Alpha Ligand Binding and F Domains Mediate Interaction and Transcriptional Synergy with the Pancreatic Islet LIM HD Transcription Factor Isl1
408
Hepatocyte Nuclear Factor 4 Is a Transcription Factor that Constitutively Binds Fatty Acids
409
Hepatocyte Nuclear Factor 4-Mediated Activation of Rat CYP3A1 Gene and Its Modes of Modulation by Apolipoprotein AI Regulatory Protein I and v-ErbA-Related Protein 3
410
Hepatocyte nuclear factor-4α plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver
411
Hepatocyte performance on different crystallographic faces of rutile
412
Hepatocyte Polyploidy and Metabolism/Life-history Traits: Hypotheses Testing
413
Hepatocyte proliferation – can we target the mechanism?
414
Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis
415
Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling
416
Hepatocyte proliferative activity in human liver cirrhosis
417
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3
418
Hepatocyte transplantation as a treatment for glycogen storage disease type 1a
419
Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies
420
Hepatocyte vacuolation and autolytic changes in the liver of pilot whales, Globicephala melas, stranded on Cape Cod, MA, USA
421
Hepatocyte-Derived MicroRNAS as Serum Predictors of Rejection of Liver Transplantation
422
Hepatocytes as a source of collagen type XVIII endostatin
423
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells
424
Hepatocyte-supported serum-free culture of rat liver sinusoidal endothelial cells
425
Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature
426
Hepatoid carcinoma of the pancreas mimicking neuroendocrine tumor
427
Hepatoid Variant of Yolk Sac Tumor of Both Ovaries With Widespread Intraabdominal and Lung Metastasis: A Case Report
428
Hepatologie : Edited by Gerok/Blum, 942, Urban & Schwarzenberg, US $ 398, ISBN 3-541-12272-2
429
Hepatology may have problems with putative surrogate outcome measures
430
Hepatoma-derived Growth Factor Represses SET and MYND Domain Containing 1 Gene Expression through Interaction with C-terminal Binding Protein
431
Hepatomegaly: A Major Clinical Sign in Some Metabolic Disorders
432
Hepatopancreas mitochondria of Mytilus galloprovincialis: effect of zinc ions on mitochondrial bioenergetics and metabolism
433
Hepatopancreatic nuclease of black tiger shrimp Penaeus monodon unlikely to be involved in viral triggered apoptosis
434
Hepatopathy and Reno-cardiopathy Induced by Ritalin in Rats
435
Hepatoprotection of sesquiterpenoids: A quantitative structure–activity relationship (QSAR) approach
436
Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats
437
Hepatoprotective Activity of “Orthosiphon stamineus” on Liver Damage Caused by Paracetamol in Rats
438
Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats
439
Hepatoprotective activity of Amaranthus spinosus in experimental animals
440
Hepatoprotective activity of Andrographis Paniculata and Swertia Chirayita
441
Hepatoprotective Activity of Camellia Sinensis and Its Possible Mechanism of Action
442
Hepatoprotective Activity of Capparis spinosa Root Bark Against CCl4 Induced Hepatic Damage in Mice
443
Hepatoprotective Activity of Caspian Saffron (Crocus caspius Fisch and Mey) Flowers against CCl4 Induced Acute Liver Injury in Mice
444
Hepatoprotective Activity of Cichorium intybus L. Leaves Extract Against Carbon Tetrachloride Induced Toxicity
445
Hepatoprotective activity of colocasia antiquorum against experimentally induced liver injury in rats
446
Hepatoprotective Activity of Cucumis trigonus Roxb. Fruit against CCl4 Inducesd Hepatic Damage in Rats
447
HEPATOPROTECTIVE ACTIVITY OF Iphiona grantioides AND Pluchea arguta FOR ACETAMINOPHEN INDUCED TOXICITY IN RABBITS
448
Hepatoprotective activity of Mammea africana ethanol stem bark extract
449
Hepatoprotective Activity of Momordica diocia Roxb Fruits in CCl4-Induced Hepatotoxicity in Rats
450
Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice
451
HEPATOPROTECTIVE ACTIVITY OF PHYLLANTHUS RETICULATUS
452
Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial
453
Hepatoprotective activity of royal jelly on mercuric chloride–induced damage model in rats
454
Hepatoprotective activity of Schouwia thebica webb
455
Hepatoprotective activity of the ethanol extract of Curcuma heyneana rhizome on isoniazid and rifampin-induced liver injury rats
456
Hepatoprotective Activity of the Ethanolic Extract of Ficus carica Linn. Leaves in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
457
Hepatoprotective activity of the extract of Homalium letestui stem against paracetamol-induced liver injury
458
Hepatoprotective activity of the total flavonoids from Rosa laevigata Michx fruit in mice treated by paracetamol
459
Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides Original Research Article
460
Hepatoprotective and antifibrotic effects of trans-chalcone against bile duct ligation-induced liver fibrosis in rats
461
Hepatoprotective and antiobesity effects of mirabegron, a novel β3-adrenoceptor agonist, on carbon tetrachloride-induced hepatotoxicity in obese rats
462
Hepatoprotective and Antioxidant Activities of Combination of Cinnamomum zeylanicum and Zingiber officinale in CCl4intoxicated Rats
463
Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves
464
Hepatoprotective and Antioxidant Activity of Euphorbia tirucalli
465
Hepatoprotective and antioxidant effects of Azolla microphylla based gold nanoparticles against acetaminophen induced toxicity in a fresh water common carp fish (Cyprinus carpio L.)
466
Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO2 on CCl4-induced liver damage
467
Hepatoprotective and antioxidant effects of Commiphora berryi (Arn) Engl bark extract against CCl4-induced oxidative damage in rats
468
Hepatoprotective and Antioxidant Effects of Eupatorium ayapana against Carbon Tetrachloride Induced Hepatotoxicity in Rats
469
Hepatoprotective and antioxidant effects of lycopene in acute cholestasis
470
Hepatoprotective and Anti-oxidant effects of Nepeta Ispahanica Boiss extract on CCL4 induced liver Injury
471
Hepatoprotective and antioxidant effects of porcine plasma protein hydrolysates on carbon tetrachloride-induced liver damage in rats
472
Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice
473
Hepatoprotective and antioxidant polyphenols from a standardized methanolic extract of the leaves of Liquidambar styraciflua L.
474
Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes
475
Hepatoprotective and Hypolipidemic Effects of Carthamus tinctorius oil in Alloxan-induced Type 1 Diabetic Rats
476
Hepatoprotective and Hypolipidemic Effects of Satureja Khuzestanica Essential Oil in Alloxan-induced Type 1 Diabetic Rats
477
Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii
478
Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga
479
Hepatoprotective constituents from Zedoariae Rhizoma: absolute stereostructures of three new carabrane-type sesquiterpenes, curcumenolactones A, B, and C Original Research Article
480
Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats
481
Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis
482
Hepatoprotective Effect of 17β-Estradiol as Antioxidant Modulators Against Stress Damage
483
Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats
484
Hepatoprotective effect of Acantholimon bracteatum (Girard) Boiss. on formaldehyde-induced liver injury in adult male mice
485
Hepatoprotective Effect of Adenema hyssopifolium G. Don (Gentianaceae) in Carbon Tetrachloride-Induced Hepatotoxicity in Rats
486
Hepatoprotective Effect of Allium hooshidaryae Hydroalcoholic Extract on Acetaminophen-Induced Hepatotoxicity in Male Rats
487
Hepatoprotective Effect of Alpha Lipoic Acid Against Bromobenzene-Induced Liver Damage in Rats
488
Hepatoprotective Effect of an Indian Salt Marsh Herb Suaeda Monoica Forsk. Ex. Gmel Against Concanavalin-A Induced Toxicity in Rats
489
Hepatoprotective Effect of Aqueous Extract of Persian Gulf Brown Algae Sargassum swartzii Against Acetaminophen-Induced Hepatotoxicity in Mice
490
HEPATOPROTECTIVE EFFECT OF CARNOSINE ON LIVER BIOCHEMICAL PARAMETERS IN CHRONIC ETHANOL INTOXICATED RAT
491
Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells
492
Hepatoprotective Effect of Coenzyme Q10 in Rats with Diclofenac Toxicity
493
Hepatoprotective Effect of Cornus mas Fruits Extract Against Carbon Tetrachloride-Induced Hepatic Damage in Male Albino Rats
494
Hepatoprotective effect of Crocus sativus (saffron) petals extract against acetaminophen toxicity in male Wistar rats
495
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
496
Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice
497
Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice
498
Hepatoprotective Effect of Ethanolic Extract of Lavandula officinalis L. in Alloxan-Induced Diabetic Rats
499
hepatoprotective effect of ethanolic extract of lavandula officinalis l.in alloxan-induced diabetic rats
500
Hepatoprotective Effect of Ficus carica Leaf Extract on Mice Intoxicated with Carbon Tetrachloride
501
HEPATOPROTECTIVE EFFECT OF GARLIC (ALLIUM SATIVUM) AND MILK THISTLE (SILYMARIN) IN ISONIAZID INDUCED HEPATOTOXICITY IN RATS
502
Hepatoprotective Effect of Glycyrrhiza Glabra in Carbon Tetrachloride-Induced Model of Acute Liver Injury
503
Hepatoprotective effect of herbal drug on CCl4 induced liver damage
504
Hepatoprotective effect of kaempferol glycosides isolated from Cedrela odorata L. leaves in albino mice: involvement of Raf/MAPK pathway
505
Hepatoprotective Effect of Lactobacillus Plantarum Against Salmonella Typhimurium in Mice
506
Hepatoprotective Effect of Matricaria chamomilla Hot Aqueous Extract Against Methomyl 90%- Induced Hepatotoxicity In Mice
507
Hepatoprotective Effect of Microemulsion-Based System of
Prunus Cerasus
Kernel Extract on CCL
4
-induced Liver Damage in Mice
508
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
509
HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE
510
Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL/6J mice
511
Hepatoprotective Effect of Otostegia persica Boiss. Shoot Extract on Carbon Tetrachloride-Induced Acute Liver Damage in Rats
512
Hepatoprotective effect of polyphenols rich methanolic extract of Amorphophallus commutatus var. wayanadensis against CCl4 induced hepatic injury in swiss albino mice
513
Hepatoprotective Effect of Pomegranate (Punica Granatum) Fruit Juice and Seed Extracts against CCL4-Induced Toxicity
514
Hepatoprotective effect of Rosa canina fruit extract against carbon tetrachloride induced hepatotoxicity in rat
515
Hepatoprotective effect of Rosmarinus officinalis and rosmarinic acid on acetaminophen-induced liver damage
516
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
517
Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect
518
Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism
519
Hepatoprotective Effect of Silymarin and Propolis in Chemically Induced Chronic Liver Injury in Rats
520
Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats
521
Hepatoprotective effect of the root extract of green tea against malathion-induced oxidative stress in rats
522
hepatoprotective effect of vitamin b12 in acetaminophen induce hepatotoxicity in male rats
523
Hepatoprotective effect of vitamins C and E against gasoline vapor-induced liver injury in male rats
524
Hepatoprotective Effect of Zizyphus vulgaris on Carbon Tetrachloride (CCl4) Induced Liver Damage in Rats as Animal Model
525
Hepatoprotective effect of β-myrcene pretreatment against acetaminophen-induced liver injury
526
Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
527
Hepatoprotective effects of almond oil against carbon tetrachloride induced liver injury in rats
528
Hepatoprotective Effects of Arbutin against Liver Damage Induced by Carbon Tetrachloride in Rats
529
Hepatoprotective effects of Artemia salina L. extract against carbon tetrachloride-induced toxicity
530
Hepatoprotective Effects of Avicennia marina (Forssk.) Vierh.
531
HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS
532
Hepatoprotective effects of betaine on liver damages followed by myocardial infarction
533
Hepatoprotective Effects of Biochanin A Against Acetaminophen-Induced Liver Toxicity in Mice
534
Hepatoprotective Effects of Black Pomegranate (Punica granatum L.) Peel Extract on Tert-Butyl Hydroperoxide Induced Oxidative Stress in Rats
535
Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice
536
Hepatoprotective Effects of Chitosan and Chitosan Nanoparticles against Biochemical, Genetic, and Histological Disorders Induced by the Toxicity of Emamectin Benzoate
537
Hepatoprotective Effects of Coenzyme Q10 against Amoxiclav-induced Hepatotoxicity in the Rat Model
538
Hepatoprotective Effects of Combination Hydroalcoholic Extracts of Nigella Sativa and Curcuma Longa on Adriamycin- Induced Oxidative Stress in Rat
539
Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice
540
Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury
541
Hepatoprotective Effects of Ethanol Extract of Caesalpiniabonduc against Carbon Tetrachloride Induced Hepatotoxicity in Albino Rats
542
Hepatoprotective effects of fermented Curcuma longa L. on carbon tetrachloride-induced oxidative stress in rats
543
Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents
544
Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats
545
Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice
546
Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats
547
Hepatoprotective Effects of Hertia cheirifolia Butanolic Extract and Selenium against CCl4 -induced Toxicity in Rats
548
Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats
549
Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice
550
Hepatoprotective effects of Lycium chinense Miller fruit and its constituent betaine in CCl4-induced hepatic damage in rats
551
Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced hepatotoxicity
552
Hepatoprotective Effects of Opuntia dillenii Haw Fruit in a Mice Model of Lung Cancer
553
Hepatoprotective Effects of Pentoxifylline against Acrolein-Induced Mitochondrial Dysfunction in Rat Liver
554
Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice
555
Hepatoprotective Effects of Propolis Extract: A Biochemical and Histopathological Approach
556
Hepatoprotective effects of purified oleuropein from olive leaf extract against ethanol-induced damages in the rat
557
Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes
558
Hepatoprotective Effects of Taraxacum officinale Root Extract on Permethrin-induced Liver Toxicity in Adult Mice
559
Hepatoprotective effects of total saponins isolated from Taraphochlamys affinis against carbon tetrachloride induced liver injury in rats
560
Hepatoprotective efficacy of Grewia asiatica fruit against oxidative stress in swiss albino mice
561
Hepatoprotective Evaluation of Butea monosperma against Liver damage by Paracetamol in Rabbits
562
Hepatoprotective glycosides from Leonurus japonicus Houtt. Original Research Article
563
Hepatoprotective Herbs, Avicenna Viewpoint
564
Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins
565
Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage
566
Hepatoprotective potential of polyphenol rich extract of Murraya koenigii L.: An in vivo study
567
Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats
568
Hepatoprotective potential of Saraca ashoka (Roxb.) De Wilde bark by carbon tetrachloride induced liver damage in rats
569
Hepatoprotective potentials of Phyllanthus amarus against ethanol-induced oxidative stress in rats
570
Hepatoprotective principles from the flowers of Tilia argentea (Linden): structure requirements of tiliroside and mechanisms of action Original Research Article
571
Hepatoprotective Properties of Cuminum cyminum Seeds Powder as Post-Treatment for Acetaminophen-Induced Injury
572
Hepatoprotective properties of p-coumaric acid in a rat model of ischemiareperfusion
573
Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway
574
Hepatoprotective properties of the glycolipoprotein extract from Eisenia foetida
575
Hepatoprotective pyrrole derivatives of Lycium chinense fruits
576
Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats
577
Hepatoprotective Role of Milk Thistle (Silybum marianum) in Meat Type Chicken Fed Aflatoxin B1 Contaminated Feed
578
HEPATOPROTECTIVE STUDIES ON HALOXYLON SALICORNICUM: A PLANT FROM CHOLISTAN DESERT
579
Hepatoprotective, anti-inflammatory and antioxidant activities of Flacourtia montana J. Grah leaf extract in male Wistar rats
580
Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica
581
Hepatoprotetive, Cardioprotective and Nephroprotective Actions of Essential Oil Extract of Artemisia sieberi in Alloxan Induced Diabetic Rats
582
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study
583
Hepatopulmonary syndrome associated with Budd-Chiari syndrome
584
Hepatopulmonary syndrome associated with cardiorespiratory disease
585
Hepatopulmonary syndrome in candidates for liver transplantation
586
Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis
587
Hepatopulmonary syndrome in transplant centres at different altitudes
588
Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data
589
Hepatopulmonary syndrome: Angiography and therapeutic embolization
590
Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS)
591
Hepatorenal and genotoxic effects of genetically modified quail meat in a 90-day dietary toxicity study in mice
592
Hepatorenal and Testicular Functions Concomitant with Induced Hypo and Hyperprolactinemia in Male Rats
593
Hepato-Renal Dysfunctions Induced by Gold Nanoparticles and Preservative Efficacy of Black Seed Oil
594
Hepatorenal effect of prolonged low-flow sevoflurane anesthesia on patients with renal impairment
595
Hepatorenal Protective Effects of Sesame Seeds Oil, Flaxseed Oil and their Mixture against Methotrexate Toxicity in Rats
596
Hepatorenal syndrome
597
Hepatorenal syndrome: Response to terlipressin and albumin and its determinants
598
Hepatorenal-toxicities Accompanying Exposure to Indoor Air Pollutants in Chemical Storekeepers at an International Market
599
Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors
600
Hepatosplenic Candidiasis Detected by ^18F-FDG-PET/CT
601
Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India
602
Hepato-Splenic gamma sigma T-Cell Lymphoma: A Rare Entity Mimicking the Hemophagocytic Syndrome
603
HEPATOSPLENIC MORBIDITY IN SCHISTOSOMIASIS JAPONICA: EVALUATION WITH DOPPLER SONOGRAPHY
604
Hepatosplenic Mucor Balls
605
Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum
606
Hepatosplenic γδ T cell lymphoma: a diagnostic pitfall
607
Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase −1 exon 8 splice junction mutation
608
Hepatotoxic and Nephrotoxic Effects of Kerosene on Female Wistar Rats: a Comparison of Two Routes of Exposure
609
Hepatotoxic Effect of Hydrogen Cyanamide (Dormex®) in Albino Rats and the Ameliorative Effect of Melatonin
610
HEPATOTOXIC EFFECT OF NICKEL SULPHATE ON MICE
611
Hepatotoxic effects of mycotoxin combinations in mice
612
Hepatotoxic microcystin diversity in cyanobacterial blooms collected in portuguese freshwaters
613
Hepatotoxicity After Exposure to Tebuconazole: A Case Report and Brief Review
614
Hepatotoxicity Among Poisoned Patients: A Cross-sectional Study
615
Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice
616
Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration
617
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice
618
HEPATOTOXICITY ASSOCIATED WITH HYPOGLYCEMIC EFFECTS OF TEUCRIUM POLIUM IN DIABETIC RATS
619
Hepatotoxicity associated with the ingestion of Papaver Rhoease
620
Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)
621
Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern
622
Hepatotoxicity Due To Mushroom Poisoning: A Case Report
623
Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting
624
Hepatotoxicity in Both Occupationally and Environmentally-Exposed Inhabitants of a Lead-Zinc Mining Community
625
Hepatotoxicity in drug development: detection, significance and solutions
626
Hepatotoxicity in sheep and goats caused by experimental feeding with foxtail millet (Setariaitalica)
627
Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study
628
Hepatotoxicity induced by iron overload and alcohol : Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation
629
Hepatotoxicity of androstenedione in pregnant rats
630
Hepatotoxicity of Antiretroviral Drugs in HIV Seropositive Nigerian Patients
631
Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management
632
HEPATOTOXICITY OF CARBON TETRACHLORIDE: PROTECTIVE EFFECT OF GONGRONEMA LATIFOLIUM
633
Hepatotoxicity of Dorema Aucheri (Bilhar) in Albino Mice
634
Hepatotoxicity of Halogenated Inhalational Anesthetics
635
Hepatotoxicity of herbal remedies
636
Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice
637
Hepatotoxicity of monobromobenzene and hexabromobenzene: effects of repeated dosage in rats
638
Hepatotoxicity of non-narcotic analgesics
639
Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials
640
Hepatotoxicity of Polyethylene Glycol and Possible Protection Using Moringa Oleifera Leaves Extract (MOLE)
641
Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser
642
Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats
643
Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly- -lysine : Synthesis of the carrier and pharmacological properties of the conjugate
644
Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines
645
Hepato-vagal pathway associated with nicotineʹs anorectic effect in the rat
646
Hepatozoon species infections in Nigeria
647
He–Pb double dating of detrital zircons from the Ganges and Indus Rivers: Implication for quantifying sediment recycling and provenance studies
648
Hepcidin and anaemia
649
Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
650
Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload
651
Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients
652
Hepcidin Gene Cloning and Expression Pattern in Turbot (Scophthalmus maximus) after Vibrio. anguillarum Infection
653
Hepcidin gene expression induced in the developmental stages of fish upon exposure to Benzo[a]pyrene (BaP)
654
Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes
655
Hepcidin in hemodialysis patients and its association with anemia and serum iron indices
656
Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?
657
Hepcidin Induces M1 Macrophage Polarization in Monocytes or THP-1 Derived Macrophages
658
Hepcidin is a friend rather than a foe in COVID19-induced complications
659
Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis
660
Hepcidin, A New Iron Regulatory Peptide
661
Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery
662
Hepcidin: A multitask molecule in fish
663
Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
664
HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium
665
HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model
666
HEPI: A new tool for human error probability calculation for offshore operation
667
HepML, an XML-based format for describing simulated data in high energy physics Original Research Article
668
HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells
669
HEP-NET OPINION ABOUT THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PAKISTAN IN THE ERA OF AVAILABLE DIRECT ACTING ANTIVIRALS
670
Hepsin promotes prostate cancer progression and metastasis
671
Hept-1-yne partial hydrogenation reaction over supported Pd and W catalysts Original Research Article
672
Heptacoordinate dithiophosphate Mo(II) and W(II) complexes: molecular structures of mono and binuclear phosphine complexes
673
Heptacoordinate dithiophosphate W(II) and Mo(II) complexes of diphosphines and iodide
674
Heptacoordinate tricarbonyl Mo(II) complexes as highly selective oxidation homogeneous and heterogeneous catalysts
675
Heptacoordinated diphenyllead; hexa- and pentacoordinated triphenyllead and tin compounds derived from 5H-benzimidazo[1,2-c]quinazoline-6-thione
676
Heptacyclo[6.6.0.02,6.03,13.04,11.05,9.010,14]tetradecane: a new type of spacer for mediating electron transfer processes
677
Heptadecafluorooctanesulfonic acid (C8F17SO3H) catalyzed intramolecular hydroamination of olefinic sulfonamides in fluorous biphase system (FBS)
678
Heptadecanols from the leaves of Persea americana var. americana
679
Heptadentate Schiff-base based PVC membrane sensor for Fe(III) ion determination in water samples
680
Heptahelical receptor signaling in heart failure
681
Heptakis(2,3-di-O-carboxymethyl)-(beta)-cyclodextrin as a pH-sensitive Host
682
Heptakis(6-deoxy-6-guanidino)-β-cyclodextrin: an artificial model for mitochondrial ADP/ATP carrier
683
Heptakis[6-S-(2,3-dihydroxypropyl)-6-thio] cyclomaltoheptaose and its sulfone: water-soluble β-cyclodextrin derivatives having modified polarity
684
Heptakis-6-(5-methylene-thioureido-5′-methyl-2,2′-bipyridyl)-β-cyclodextrin: synthesis and metal complexation study
685
Heptakis-6-(5-methylene-ureido-5′-methyl-2,2′-bithiazolyl)-cyclomaltoheptaose as a new fluorescent polydentate ligand
686
Heptane isomerization over molybdenum oxides obtained by H2 reduction of HxMoO3 with different hydrogen contents Original Research Article
687
Heptane Reforming over Pt–Re/Al2O3: Reaction Network, Kinetics, and Apparent Selective Catalyst Deactivation
688
Heptanuclear and Decanuclear Manganese Complexes with the Anion of 2-Hydroxymethylpyridine
689
Heptanuclear cobalt(II) dicubane compounds with single-molecule magnet behavior
690
Heptaphyrins: Expanded porphyrins with seven heterocyclic rings
691
Heptyl oleate synthesis as useful tool to discriminate between lipases, proteases and other hydrolases in crude preparations
692
Her 2 in 1
693
Her 2 Overexpression in Breast Carcinoma; Its Significance and Association with Age and Tumor Grade
694
Her Majesty’s coroners and Home Office forensic pathologists perception of the nurses’ role in the coroner’s enquiry
695
Her records
696
Her story of cognitive science
697
HER2 aberrations in cancer: Implications for therapy
698
HER2 and proliferation of wound-induced breast carcinoma
699
HER2 and proliferation of wound-induced breast carcinoma
700
HER2 and proliferation of wound-induced breast carcinoma
701
HER2 and surgery: more questions to answer
702
HER2 discordance between primary and metastatic breast cancer: Assessing the clinical impact
703
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization
704
HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma
705
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer—A study of two hundred cases
706
HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer
707
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors
708
HER2 Overexpression in Borderline and Malignant Ovarian Tumors: A Cross-sectional Study in an Iranian Population and Literature Review
709
HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription
710
HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement
711
HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana
712
HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer
713
HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer
714
HER2 status in advanced breast cancer: which option for aromatase inhibitors?
715
HER2 Testing in Invasive Breast Cancer: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization Assays
716
HER2 testing: Current status and future directions
717
HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?
718
HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia
719
HER2/neu expression in bladder cancer: relationship to cell cycle kinetics
720
Her-2/Neu Expression in Bladder Urothelial Carcinoma
721
HER-2/neu Expression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage
722
Her2/neu Expression in Wilmsʹʹ Tumor and Correlation With Histopathologic Findings
723
HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability
724
HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma
725
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
726
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
727
HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features
728
Her-2/Neu, Estrogen and Progesterone Receptor Expression In WHO Grade I Meningiomas
729
HER2/neu: A Prognostic Marker for Ovarian Carcinoma
730
HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization
731
HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion
732
HER2-Positive Breast Cancer: Tumor-to-Liver SUV Ratio is the Best Parameter for Detection in F-18 FDG-PET/CT
733
Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting
734
HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors
735
HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
736
HER-3 Knocking Down Induces G2/M Arrest in Gastric Cancer Cells
737
HER4 rs1595065 3ʹUTR Variant is a Possible Risk Factor for HER2 Positivity Among Breast Cancer Patients
738
HERA and the asymptotic behaviour of F2p
739
HERA anomaly and hard charm in the nucleon
740
HERA collider physics
741
HERA data and DGLAP evolution: Theory and phenomenology
742
HERA events, tevatron jets, and uncertainties on quarks at large x
743
HERA prospects on compositeness and new vector bosons
744
HERA results on electroweak interactions at high momentum transfers
745
HERA results on the structure of the proton
746
HERA today, gone tomorrow?
747
HERA-3 Original Research Article
748
HERA-B data acquisition system
749
HERA-B data acquisition system
750
HERA-B framework for online calibration and alignment
751
HERA-B framework for online calibration and alignment
752
HERA-B higher-level triggers: architecture and software
753
HERA-B higher-level triggers: architecture and software
754
HERA-B RICH
755
HERA-B RICH
756
HERA-B RICH light collection system
757
HERA-B RICH light collection system
758
HERA-B RICH: Performance and physics impact
759
HERA-B RICH: Performance and physics impact
760
HERA-B status
761
HERA-B status
762
HERA-B triggering
763
HERA-B, an experiment to study CP violation at the HERA proton ring using an internal target
764
HERA-B: overview and 1996 engineering run
765
HERA-B: overview and 1996 engineering run
766
HERA-B: overview and engineering runs
767
HERA-B: overview and engineering runs
768
HERA-B: physics potential and prospects
769
HERA-B: physics potential and prospects
770
HERA-B: status and commissioning results
771
HERA-B: status and commissioning results
772
HERA-B: trigger system
773
HERA-B: trigger system
774
HERACLES-II setup at TRIUMF
775
HERACLES-II setup at TRIUMF
776
HERA-data in the light of small x evolution with state of the art NLO input
777
Heraeus acquires BASFʹs business in ceramic & glassware colorants
778
Herakles’in On İki İşi Betimli Mozaik Hakkında Tespitler
779
Heralded two-photon entanglement from probabilistic quantum logic operations on multiple parametric down-conversion sources
780
Herb and vitamin upplementation ue among a general ophthalmology practice population
781
Herb digoxin interactions
782
Herb gallwasp Neaylax salviae (Giraud, 1859) (Hymenoptera, Aylacini) – new record from Turkey
783
Herb layer extinction debt in highly fragmented temperate forests – Completely paid after 160 years?
784
Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats
785
Herb Target Prediction Using Machine Learning Methods in a Heterogeneous Network
786
Herbaceous biomass retrieval in habitats of complex composition: a model merging SAR images with unmixed Tlandsat TM data
787
Herbaceous energy crops: A general survey and a microeconomic analysis
788
Herbaceous layer response to 17 years of controlled deer hunting in forested natural areas
789
Herbaceous plant biomass harvest and delivery cost with harvest segmented by month and number of harvest machines endogenously determined
790
Herbaceous vegetation response to grazing exclusion in patches and inter-patches in semi-arid pasture and woody encroachment
791
Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway
792
Herbage and Animal Responses to Management Intensity of Continuously Stocked Bahiagrass Pastures
793
Herbage and Seed Production of Two Species of Lathyrus L. under Rainfed Condition of Borujerd, Iran
794
Herbage biomass production and nutritive value of mulberry (Morus alba) and Calliandra calothyrsus harvested at different cutting frequencies
795
Herbage intake and milk yield of dairy cows grazing perennial ryegrass swards or white clover/perennial ryegrass swards at low- and medium-herbage allowances
796
HERBAGE MINERAL NUTRITION INDEXED AS TOOLS FOR RAPID MINERAL STATUS DIAGNOSIS IN TROPICAL PASTURES
797
Herbage production and chemical characteristics for bioenergy production by plant functional groups from semi-natural grasslands
798
Herbage yield in Signalgrass pastures as affected by grazing management
799
Herbage yield of Persian clover (Trifolium resupinatum L.) as affected by row distance and herbicide application
800
Herbal agents and over-the-counter medications in pregnancy
801
Herbal and Conventional Toothpastes Roles in Gingivitis Control in Orthodontic Patients
802
Herbal and Dietary Supplement–Drug Interactions in Patients Taking Digoxin
803
Herbal and nutritional supplement use among college students in Qatar
804
Herbal Appetizer for Children with Failure to Thrive (FTT) in View of Traditional Persian Medicine: A Review
805
HERBAL APPROACHES FOR EPILEPSY: A REVIEW
806
Herbal Cosmeceuticals for Photoprotection from Ultraviolet B Radiation: A Review
807
Herbal cosmeceuticals: New opportunities in cosmetology
808
Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products
809
Herbal Drugs with Promising Anti-Leishmanial Activity: New Hope for Leishmaniasis Treatment
810
Herbal Extract Decolourization Device Using Activated Carbon
811
Herbal extracts and essential oils microencapsulation studies for different applications
812
Herbal Fertility Remedies Leading to Massive Pulmonary Embolism: A Case Report
813
Herbal formula CGX ameliorates LPS/d-galactosamine-induced hepatitis
814
Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports
815
Herbal infusions bioelectrochemical polyphenolic index: Green tea – The gallic acid interference
816
Herbal infusions; their phenolic profile, antioxidant and anti-inflammatory effects in HT29 and PC3 cells
817
HERBAL INTAKE: UNDIAGNOSED HYPOTHYROIDISM LEADING TO POSTOPERATIVE REFRACTORY CIRCULATORY COLLAPSE - A Case Report -
818
Herbal Medications to Manage Insomnia: An Overview of Clinical Trials using Herbal Treatment for Insomnia
819
Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential
820
Herbal Medicinal Products, Medpharm, Stuttgart, Germany, F. Gaedcke, B. Steinhoff, H. Blasius (Eds.). CRC Press, Boca Raton, USA (2003)
821
Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry
822
Herbal medicine and liver disease, for any conclusion we need to do more studies
823
Herbal Medicine and Sexual Behavior in Diabetic Patients
824
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
825
Herbal Medicine and Vaginal Candidiasis in Iran: A Review
826
Herbal Medicine as Inducers of Apoptosis in Cancer Treatment
827
Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview
828
Herbal medicine heads for the mainstream
829
Herbal Medicine in the Treatment of Premenstrual Syndromes
830
Herbal Medicine in Treatment of Recurrent Aphthous Stomatitis: A Literature Review
831
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
832
Herbal Medicine Isolation, Phaleria macrocarpa for primary glioblastoma multiforme cells
833
Herbal medicine Sho-saiko-to (TJ-9) prevent liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient -amino acid-defined diet
834
Herbal medicine under scrutiny
835
Herbal Medicine, Second Edition.: Rudolf Fritz Wiess, MD and Volker Fintelmann, MD. ISBN 0-86577-970-8, Thieme, NY, 438 pp.
836
Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects
837
Herbal Medicines and Epilepsy: To the Editor
838
Herbal Medicines and Other Traditional Remedies in Iran – A Tragedy Unfolds
839
Herbal Medicines and Reactivation of Chronic Hepatitis B Virus Infection
840
Herbal Medicines for Immunosuppression
841
Herbal Medicines in Diabetes
842
Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders
843
Herbal Medicines Used in Kidney Diseases in Europe
844
Herbal Medicines Used in Treatment of Nonalcoholic Fatty Liver Disease: A Mini-Review
845
Herbal medicines: a new hope for autism therapy
846
Herbal Medicines: from Traditional Medicine to Modern Experimental Approaches
847
Herbal medicines—primum non nocere
848
Herbal Nanoemulsion in Topical Drug Delivery and Skin Disorders: Green Approach
849
Herbal nano-ointment containing encapsulated polysaccharide in repairing of superficial ulcers
850
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
851
Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review
852
Herbal Products in the Care and Prevention of Breast Fissure in Lactating Women: A Systematic Review
853
Herbal Products Review Provides Inaccurate Information on Dietary Supplement Regulations
854
Herbal Products Review: What Do We Really Know?
855
Herbal Products Use During Pregnancy in North of Iran
856
Herbal remedies and medicine; introducing some Iranian plants
857
Herbal Remedies CD-ROM, T. Brendler, J. Gruenwald, C. Jaenicke (Eds.). Medpharm GmbH Scientific Publishers, Stuttgart Germany (2003)
858
Herbal Remedies Connected to Malaria like Fever in Iranian Ancient Medicinal Books- Brief Review Article.
859
Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis
860
Herbal Remedies for Acne Vulgaris from the Viewpoint of Persian Medicine
861
Herbal Remedies for Cancer based on Persian Medicine
862
Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective
863
Herbal remedies for oligomenorrhea in Traditional Persian Medicine
864
Herbal Remedies for Pediatric Earache in Traditional Iranian Medicine
865
Herbal remedies—how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity
866
Herbal Research: Gaps Affecting the Quality and Validity of Research Findings
867
HERBAL RMIDIES USED FOR GASTROINTESTINAL DISORDERS IN KAGHAN VALLEY, NWFP, PAKISTAN
868
Herbal self-medication use in patients with diabetes mellitus type 2
869
Herbal Supplement Use and Herb–drug Interactions among Patients with Kidney Disease
870
Herbal supplementation diets on hematology and innate immunity in goldfish against Aeromonas hydrophila
871
Herbal Therapy and Treatment of Worm Infections, Emphasizing Taenia solium
872
Herbal Therapy for Burn Wound Infections
873
Herbal therapy in Covid-19: A systematic review of medicinal plants effective against Covid-19
874
Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials
875
HERBAL TREATMENT FOR CARDIOVASCULAR DISEASE THE EVIDENCE BASED THERAPY
876
Herbal Treatment of Hypertension: A Literature Review
877
Herbal Treatment of Oligomenorrhea with Sesamum indicum L.: A Randomized Controlled Trial
878
Herbal treatment options for female fertility disorders: a systematic review of clinical trials
879
Herbal Treatments for Asthma, according to Avicenna
880
Herbal Treatments to Gain Weight as the Potential Cause of Portal Vein Thrombosis and Hepatic Damage: A Case Report
881
Herbal Whitening Agents: Traditional Remedies for Reducing Tooth Discoloration
882
Herbal, Animal and Mineral Remedies in Burn Wound: a review of Persian Traditional Medicine literature
883
Herbal-caffeinated chewing gum, but not bubble gum, improves aspects of memory
884
Herbals in cardiovascular practice: Are physicians neglecting anything?
885
Herbarium images launched
886
Herbarium specimens demonstrate earlier flowering times in response to warming in Boston
887
Herb–drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice
888
Herb-drug interactions
889
Herb-drug interactions
890
Herb–drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats
891
Herbert Blankenhorn in the Third Reich
892
Herbert Bower
893
Herbert D. Kelleher, Southwest Airlines, 2003 Bower Award for Business Leadership laureate
894
Herbert Holik (Ed.), Handbook of paper and board, Wiley-VCH, Weinheim, Germany, 2006 (xix+505, £105-00, ISBN: 3-527-30997-7)
895
Herbert Robbins and sequential analysis
896
Herbert screw fixation of capitellar fractures
897
Herbert Simon and behavioral economics
898
Herbert Simon and the concept of dispersed entrepreneurship
899
Herbert Simon. Artificial intelligence as a framework for understanding intuition
900
Herbicidal activity of allelopathic extracts of sorghum and some herbicides on wheat and accompanied weeds
901
Herbicidal activity of constituents isolated from Solanum elaeagnifolium (Solanaceae)
902
HERBICIDAL ACTIVITY OF Datura metel L. AGAINST Phalaris minor Retz
903
Herbicidal activity of eight isothiocyanates on Texas panicum (Panicum texanum), large crabgrass (Digitaria sanguinalis), and sicklepod (Sennaobtusifolia)
904
Herbicidal Activity of Mycelial and Cell Free Extracts of Fusarium oxysporum F.sp. Ciceris Against Rice Weed Cyperus Iria l
905
HERBICIDAL ACTIVITY OF SOME MEDICINAL PLANTS EXTRACTS AGAINST Parthenium hysterophorus L.
906
Herbicidal and antioxidant responses of transgenic rice overexpressing Myxococcus xanthus protoporphyrinogen oxidase
907
HERBICIDAL CONTROL OF Lantana camara
908
HERBICIDAL EFFECT OF FICUS BENGALENSIS AQUEOUS EXTRACT ON IPOMOEA PENTAPHYLLA
909
Herbicidal effects under field conditions of Ailanthus altissima bark extract, which contains ailanthone
910
Herbicidal ionic liquid with dual-function
911
Herbicidal potential of Azadirachta indica leaves extract against Achyranthes aspera and Senna occidentalis
912
Herbicidal, Insecticidal and Structure-Activity Relationship Studies on Pyranopyrazole and Oxinobispyrazole Derivatives
913
Herbicide accumulation and evolution in reservoir sediments Original Research Article
914
Herbicide and insect resistant elite transgenic rice
915
Herbicide and metabolite movement in different soils as studied by computer assisted microlysimeters
916
Herbicide and plant growth regulator analysis by capillary electrophoresis
917
Herbicide concentrations in the Mississippi River Basin—the importance of chloroacetanilide herbicide degradates
918
Herbicide contamination and dispersion pattern in lowland springs Original Research Article
919
Herbicide contamination and the potential impact to seagrass meadows in Hervey Bay, Queensland, Australia
920
HERBICIDE CONTAMINATION IN CARROT GROWN IN PUNJAB, PAKISTAN
921
Herbicide contamination of surficial groundwater in Northern Italy
922
Herbicide dissipation and dynamics modelling in three different tillage systems
923
Herbicide distribution in soils of a riparian forest and neighboring sugar cane field
924
Herbicide dose and incorporation depth in combination with 1,3- dichloropropene plus chloropicrin for Cyperus rotundus control in tomato and pepper
925
Herbicide drift can affect plant and arthropod communities
926
Herbicide effect on growth and seed production of Lolium multiflorum in Atlantic Canada
927
Herbicide effects on typha latifolia (Linneaus) germination and root and shoot development
928
Herbicide evaluation for the control of wild taro
929
Herbicide impact on Hormosira banksii gametes measured by fluorescence and germination bioassays
930
Herbicide Isoproturon-Specific Binding in the Freshwater Macrophyte Elodea densa-A Single-Cell Fluorescence Study
931
Herbicide loss in surface runoff from a pastoral hillslope in the Pukemanga catchment (New Zealand): Role of pre-event soil water content
932
Herbicide losses in runoff events from a field with a low slope: Role of a vegetative filter strip
933
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants CoExpressing Human CYP1A1, CYP2B6, and CYP2C19
934
Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants Expressing Human CYP1A1
935
Herbicide Metabolism and Tolerance in the Transgenic Rice Plants Expressing Human CYP2C9 and CYP2C19
936
Herbicide Residues in Water Resources: A Scoping Review
937
Herbicide Resistance and Supersensitivity in Ala250 or Ala251 Mutants of the D1 Protein in Chlamydomonas reinhardtii,
938
Herbicide resistance dynamics in a spatially heterogeneous environment
939
HERBICIDE RESISTANCE IN ANNUAL RYEGRASS (Lolium rigidum Gaud.) POPULATIONS IN WHEAT FIELDS OF FIROOZABAD IRAN
940
Herbicide Retention in Soil as Affected by Sugarcane Mulch Residue
941
Herbicide risk assessment for non-target aquatic plants: sulfosulfuron - a case study
942
Herbicide safeners: uses, limitations, metabolism, and mechanisms of action
943
Herbicide Selectivity applied in post-emergence of Mulato II grass
944
Herbicide sensitivity of Echinochloa spp. accessions in Italian rice fields
945
Herbicide sorption, degradation, and leaching in three Swedish soils under long-term conventional and reduced tillage
946
Herbicide tolerance in maize is related to increased levels of glutathione and glutathione-associated enzymes
947
Herbicide toxicity of Halophila ovalis assessed by chlorophyll a fluorescence
948
Herbicide transport by surface runoff and herbicide retention in a filter strip — Rainfall and runoff simulation studies
949
Herbicide transport via surface runoff during intermittent artificial rainfall: A laboratory plot scale study
950
Herbicide/Pesticide Effects on Intestinal Epithelial Growth,
951
Herbicides affect fluorescence and electron transfer activity of spinach chloroplasts, thylakoid membranes and isolated Photosystem II
952
Herbicides and herbicide degradates in shallow groundwater and the Cedar River near a municipal well field, Cedar Rapids, Iowa
953
Herbicides and Herbicide Degradation Products in Upper Midwest Agricultural Streams during August BaseFlow Conditions
954
Herbicides and nitrogen in precipitation: progression from west to east and contribution to the Marne river (France)
955
HERBICIDES AND THEIR DOSES EFFECTS ON WILD ONION (Asphodelus tenuifolius Cav.) IN CHICKPEA
956
Herbicides and their mechanisms of action. Sheffield Biological Sciences, Volume 6. Edited by Andrew Cobb and Ralph Kirkwood. 2000.
957
Herbicides and Transformation Products in Surface Waters of the Midwestern United States
958
Herbicides for control of isoproturon-resistant Littleseed Canarygrass (Phalaris minor) in wheat
959
Herbicides for control of metsulfuron resistant toothed dock (Rumex dentatus)
960
Herbicides genotoxicity
961
Herbicides genotoxicity
962
Herbicides have negligible effects on ants and springtails in an Australian wheat field
963
Herbicides have negligible effects on ants and springtails in an Australian wheat field
964
Herbicides implicated as the cause of severe mangrove dieback in the Mackay region, NE Australia: consequences for marine plant habitats of the GBR World Heritage Area
965
HERBICIDES, THEIR APPLICATION TIMINGS AND DIFFERENT SOIL TEMPERATURE REGIMES AFFECT WEED INFESTATION IN WHEAT
966
Herbicides, weeds and endangered species: management of bitou bush (Chrysanthemoides monilifera ssp. rotundata) with glyphosate and impacts on the endangered shrub, Pimelea spicata Original Research Article
967
Herbicide-tolerant sugarcane (Saccharum officinarum L.) plants: an unconventional method of weed removal
968
Herbivore and pollinator responses to grassland management intensity along experimental changes in plant species richness
969
Herbivore diet selection in response to simulated variation in nutrient rewards and plant secondary compounds
970
Herbivore host choice and optimal bad motherhood
971
Herbivore species and density affect vegetation-structure patchiness in salt marshes
972
Herbivore-associated elicitors: FAC signaling and metabolism
973
Herbivore-associated elicitors: FAC signaling and metabolism
974
Herbivore-induced coexistence of competing plant species
975
Herbivore-Induced Defense Response in a Model Legume. Two-Spotted Spider Mites Induce Emission of (E)-(beta)Ocimene and Transcript Accumulation of (E)-(beta)-Ocimene Synthase in Lotus japonicus
976
Herbivores alter the fitness benefits of a plant–rhizobium mutualism
977
Herbivores Coprolites from Chehrabad Salt Mine of Zanjan, Iran (Sassanid Era, 224-651 AD) Reveals Eggs of Strongylidae and Anoplocephalidae Helminths
978
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
979
Herbivores enable plant survival under nutrient limited conditions in a model grazing system
980
Herbivores, the Functional Diversity of Plants Species, and the Cycling of Nutrients in Ecosystems
981
Herbivorous and microbial grazing pathways of metazooplankton in the Senegal River Estuary (West Africa)
982
Herbivory alters competitive interactions between two invasive aquatic plants
983
Herbivory alters the expression of a mixed-mating system
984
Herbivory and seedling performance in a fragmented temperate forest of Chile
985
Herbivory at marginal populations: Consequences for maternal fitness and vegetative differentiation
986
Herbivory by the pine weevil (Hylobius abietis L.) and short-snouted weevils (Strophosoma melanogrammum Forst. and Otiorhynchus scaber L.) during the conversion of a wind-thrown Norway spruce forest into a mixedspecies plantation
987
Herbivory by the weevil, Strophosoma melanogrammum, causes severalfold increase in emission of monoterpenes from young Norway spruce (Picea abies)
988
HERBIVORY COULD UNLOCK MUTATIONS SEQUESTERED IN STRATIFIED SHOOT APICES OF GENETIC MOSAICS
989
Herbivory in a Mediterranean forest: browsing impact and plant compensation
990
Herbivory in early Tertiary Arctic forests
991
Herbivory on macro-algae affects colonization of beach-cast algal wrack by detritivores but not its decomposition
992
Herbivory passing the limits
993
Herbivory responsive C2H2 zinc finger transcription factor protein StZFP2 from potato
994
Herbivory, foliar survival and shoot growth in fragmented populations of Aristotelia chilensis
995
Herbivory, hunting, and long-term vegetation change in degraded savanna Review Article
996
Herbivory, induced resistance, and interplant signal transfer in Alnus glutinosa
997
Herbological and agrotechnological approaches to weeding plants in modern flax growing
998
Herbological and agrotechnological approaches to weeding plants in modern flax growing
999
Herbrand theorems in arbitrary institutions
1000
Herbs and alternative therapies in the hypertension clinic
